Mayumi Idei

460 total citations
25 papers, 297 citations indexed

About

Mayumi Idei is a scholar working on Nephrology, Surgery and Physiology. According to data from OpenAlex, Mayumi Idei has authored 25 papers receiving a total of 297 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Nephrology, 6 papers in Surgery and 6 papers in Physiology. Recurrent topics in Mayumi Idei's work include Dialysis and Renal Disease Management (8 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers) and Muscle and Compartmental Disorders (3 papers). Mayumi Idei is often cited by papers focused on Dialysis and Renal Disease Management (8 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers) and Muscle and Compartmental Disorders (3 papers). Mayumi Idei collaborates with scholars based in Japan, Sweden and United States. Mayumi Idei's co-authors include Takashi Miida, Yuki Horiuchi, Yoko Tabe, Mototsugu TANAKA, Satoshi Hirayama, Tsuyoshi Ueno, Hiroshi Sakaguchi, Hirotoshi Ohmura, Akimichi Ohsaka and Toshiyuki Hata and has published in prestigious journals such as PLoS ONE, Clinical Pharmacology & Therapeutics and Critical Care.

In The Last Decade

Mayumi Idei

25 papers receiving 296 citations

Peers

Countries citing papers authored by Mayumi Idei

Since Specialization

Citations

This map shows the geographic impact of Mayumi Idei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mayumi Idei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mayumi Idei more than expected).

Fields of papers citing papers by Mayumi Idei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mayumi Idei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mayumi Idei. The network helps show where Mayumi Idei may publish in the future.

Co-authorship network of co-authors of Mayumi Idei

This figure shows the co-authorship network connecting the top 25 collaborators of Mayumi Idei. A scholar is included among the top collaborators of Mayumi Idei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mayumi Idei. Mayumi Idei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Seroprevalence of anti-SARS-CoV-2 antibodies in Japanese COVID-19 patients 2021 ·PLoS ONE ·Makoto Hiki, Yoko Tabe, Tomohiko Ai, Yuya Matsue, Norihiro Harada, Kiichi Sugimoto, Yasushi Matsushita, Masakazu Matsushita, (unknown), Shigeki Misawa, Mayumi Idei, Takashi Miida, Naoto Tamura, Kazuhisa Takahashi, Toshio Naito	7
2	Comparison of the clinical performance and usefulness of five SARS-CoV-2 antibody tests 2021 ·PLoS ONE ·(unknown), Mayumi Idei, Kaori Saito, Yuki Horiuchi, (unknown), (unknown), Takamasa Yamamoto, (unknown), (unknown), (unknown), (unknown), Sho Takahashi, (unknown), Shigeki Misawa, Chihiro Akazawa, Toshio Naito, Takashi Miida, Kazuhisa Takahashi, Tomohiko Ai, Yoko Tabe	16
3	Rationales of delay and difference in regulatory review by Japan, the USA and Europe among new drugs first approved in Japan 2021 ·British Journal of Clinical Pharmacology ·Mototsugu TANAKA, Mayumi Idei, Hiroshi Sakaguchi, (unknown), (unknown), (unknown), (unknown), Toshiyuki Hata, (unknown), (unknown), Mutsuhiro Ikuma	6
4	Effluent N‐terminal expressed in renal cell carcinoma/mesothelin predicts increased peritoneal permeability in patients undergoing peritoneal dialysis 2021 ·Therapeutic Apheresis and Dialysis ·Mayumi Idei, Masaaki Abe, Mototsugu TANAKA, Junichiro Nakata, (unknown), Okio Hino, Takashi Miida	1
5	Hospitalization for Patients on Combination Therapy With Peritoneal Dialysis and Hemodialysis Compared With Hemodialysis 2020 ·Kidney International Reports ·Mototsugu TANAKA, Yoshitaka Ishibashi, Yoshifumi Hamasaki, (unknown), Mayumi Idei, Takuya Kawahara, Takahiro Nishi, Michio Takeda, (unknown), Masaomi Nangaku, Naobumi Mise	7
6	Preβ1-high-density lipoprotein metabolism is delayed in patients with chronic kidney disease not on hemodialysis 2020 ·Journal of clinical lipidology ·(unknown), Satoshi Hirayama, (unknown), (unknown), (unknown), Koya Suzuki, Mayumi Idei, Masaki Kitahara, Takashi Miida	6
7	Evolving Landscape of New Drug Approval in Japan and Lags from International Birth Dates: Retrospective Regulatory Analysis 2020 ·Clinical Pharmacology & Therapeutics ·Mototsugu TANAKA, Mayumi Idei, Hiroshi Sakaguchi, (unknown), (unknown), (unknown), (unknown), Toshiyuki Hata, (unknown), (unknown), Mutsuhiro Ikuma	36
8	Ultrafiltration volume by once‐weekly hemodialysis is a predictor of technique survival of combination therapy with peritoneal dialysis and hemodialysis 2020 ·Therapeutic Apheresis and Dialysis ·Mototsugu TANAKA, Yoshitaka Ishibashi, Yoshifumi Hamasaki, (unknown), Mayumi Idei, Takahiro Nishi, Michio Takeda, (unknown), Masaomi Nangaku, Naobumi Mise	2
9	Health-related quality of life on combination therapy with peritoneal dialysis and hemodialysis in comparison with hemodialysis and peritoneal dialysis: A cross-sectional study 2020 ·Peritoneal Dialysis International ·Mototsugu TANAKA, Yoshitaka Ishibashi, Yoshifumi Hamasaki, (unknown), Mayumi Idei, Takuya Kawahara, Takahiro Nishi, Michio Takeda, (unknown), Masaomi Nangaku, Naobumi Mise	16
10	Apolipoproteins C-II and C-III as nutritional markers unaffected by inflammation 2018 ·Clinica Chimica Acta ·(unknown), Satoshi Hirayama, Tsuyoshi Ueno, Masayuki Itô, (unknown), (unknown), (unknown), (unknown), Mayumi Idei, Takashi Miida	7
11	Changes in apolipoprotein E-containing high-density lipoprotein (HDL) have little impact on HDL-cholesterol measurements using homogeneous assays in normolipidemic and dyslipidemic subjects 2017 ·Clinica Chimica Acta ·(unknown), Satoshi Hirayama, (unknown), (unknown), Tsuyoshi Ueno, (unknown), (unknown), (unknown), Mayumi Idei, (unknown), Takashi Miida	4
12	Pancreatic lipase activity in overnight effluent predicts high transport status in peritoneal dialysis patients 2016 ·Clinica Chimica Acta ·Mayumi Idei, Yoko Tabe, Chieko Hamada, (unknown), Hiroyuki Takemura, Hiroaki Io, (unknown), (unknown), Yasuhiko Tomino, Akimichi Ohsaka, Takashi Miida	2
13	Mean postprandial triglyceride concentration is an independent risk factor for carotid atherosclerosis in patients with type 2 diabetes 2014 ·Clinica Chimica Acta ·Mayumi Idei, Satoshi Hirayama, Noriko Miyake, (unknown), Yuki Horiuchi, Tsuyoshi Ueno, (unknown), (unknown), Hidenori Yoshii, (unknown), Tomio Onuma, Takashi Miida	16
14	Performance evaluation of the digital cell imaging analyzer DI-60 integrated into the fully automated Sysmex XN hematology analyzer system 2014 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·Yoko Tabe, (unknown), (unknown), (unknown), Mayumi Idei, (unknown), Takashi Miida, Akimichi Ohsaka	35
15	Performance Evaluation of the Automated Morphological Analysis of Erythrocytes by CellaVision DM96 2013 ·Clinical Laboratory ·(unknown), Yoko Tabe, Hans‐Inge Bengtsson, Kiyoshi Ishii, (unknown), Yuki Horiuchi, Mayumi Idei, (unknown), (unknown), Takashi Miida, Akimichi Ohsaka	6
16	Albumin concentration determined by the modified bromocresol purple method is superior to that by the bromocresol green method for assessing nutritional status in malnourished patients with inflammation 2013 ·Annals of Clinical Biochemistry International Journal of Laboratory Medicine ·Tsuyoshi Ueno, Satoshi Hirayama, Masayuki Itô, (unknown), Yoshifumi Fukushima, T Satoh, Mayumi Idei, Yuki Horiuchi, Hiromichi Shoji, Hirotoshi Ohmura, Toshiaki Shimizu, Takashi Miida	37
17	The use of CellaVision competency software for external quality assessment and continuing professional development 2011 ·Journal of Clinical Pathology ·Yuki Horiuchi, Yoko Tabe, Mayumi Idei, Hans‐Inge Bengtsson, Kiyoshi Ishii, (unknown), (unknown), (unknown), Takashi Miida, Akimichi Ohsaka	7
18	Statin therapy reduces inflammatory markers in hypercholesterolemic patients with high baseline levels 2010 ·Journal of Atherosclerosis and Thrombosis ·Yuki Horiuchi, Satoshi Hirayama, Satoshi Soda, (unknown), (unknown), Tsuyoshi Ueno, Mayumi Idei, Osamu Hanyu, Takashi Tsuda, Hirotoshi Ohmura, Takashi Miida	29
19	Profiles of inflammatory markers and lipoprotein subclasses in patients undergoing continuous ambulatory peritoneal dialysis 2010 ·Clinica Chimica Acta ·(unknown), Satoshi Hirayama, Yuki Horiuchi, Tsuyoshi Ueno, Mayumi Idei, (unknown), (unknown), Shin Goto, Hiroki Maruyama, Noriaki Iino, Yoshifumi Fukushima, Hirotoshi Ohmura, Yuji Hirowatari, Takashi Miida	9
20	[Serum zinc concentration decreases with age and is associated with anemia in middle-aged and elderly people]. 2010 ·PubMed ·Mayumi Idei, (unknown), Yuki Horiuchi, Yoko Tabe, Noriko Miyake, (unknown), Takashi Miida	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact